News for hackers. Stuff that matters.
Re:Conclusions from analyzing Y Combinator’s investing history by aaavl2821 on Friday December 27, 2019 @10:19PM (#21896829)
Biotech is the second largest sector of VC after software. $15B was invested in biotech startups in 2019. The biggest subsector of biotech VC is startups working on cancer drugs.

However there is zero overlap between the top biotech VCs and top tech VCs (including YC) so awareness of biotech is low outside of the industry

Re:Conclusions from analyzing Y Combinator’s investing history by DrAwdeOccarim on Saturday December 28, 2019 @07:14AM (#21898500)
What do you mean zero overlap? YC does biotech (https://www.ycombinator.com/biotech/).
Re:Conclusions from analyzing Y Combinator’s investing history by aaavl2821 on Saturday December 28, 2019 @10:03AM (#21899216)
I just meant zero overlap among the top VCs. YC is doing some really cool things in biotech but they are pretty new to it. In terms of dollars invested, exits and returns, the top biotech VCs are funds like the column group, orbimed, 5am, versant, foresite, flagship, third rock, atlas, arch, sofinnova. These funds only do biotech and have been doing it for decades